Things I Do But Should I: Warfarin
From November 2016, Aspirin Loses Its TenureIn this chapter of things I do but should I: A patient with low INR, to bridge or not to bridge with heparin; How often should patients with stable INR be monitored; what’s the proper warfarin starting dose; when starting warfarin, do we need to bridge with heparin until the INR is therapeutic? •
16min 44Vanessa Cardy, MD and Adrien Selim, MD
New Venous Thromboembolism Guidelines
From April 2016, New Venous Thromboembolism GuidelinesJust published in the February 2016 edition of Chest, "Antithrombotic Therapy for VTE Disease" sheds some light on a few of the confusing aspects of VTE management. In this short, we discuss outpatient management of pulmonary embolism; what to do when a patient is therapeutic on an oral …
7min 18Andrew Buelt, DO and Rob Orman, MD
Paper Chase 4: Anticoagulant Treatment for Unprovoked Pulmonary Embolism
From February 2016, The Allergy That Isn't and the B-12 That IsAmong patients with a first episode of unprovoked pulmonary embolism who received 6 months of anticoagulant treatment, an additional 18 months of treatment with warfarin reduced the composite outcome of recurrent venous thrombosis and major bleeding compared with placebo. •
5min 41Andrew Buelt, DO and Joe Weatherly, DO